New combo therapy offers hope for liver disease patients not helped by standard drug
NCT ID NCT05749822
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for adults with primary biliary cholangitis (a chronic liver disease) who also have cirrhosis and did not respond well to the usual treatment, ursodeoxycholic acid. Researchers want to see if adding fenofibrate to their treatment can improve liver health by normalizing a key enzyme level. About 104 participants will take the combination and be monitored for up to 36 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, China
Contact Phone: •••-•••-••••
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-sen Memorial Hospital
NOT_YET_RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Kunming Medical University
RECRUITINGKunming, Yunnan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Medical University General Hospital
RECRUITINGTianjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Third Central Hospital
RECRUITINGTianjin, Tianjin Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya Hospital Central South University
RECRUITINGChangsha, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xijing Hospital
RECRUITINGXi'an, Shaanxi, China
Contact
-
Yan'an University Affiliated Hospital
RECRUITINGYan’an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartwatch help manage a rare liver disease? stanford study investigates
- New study tracks blood sugar in liver disease patients on common drug
- Promising new treatment for rare liver disease shows potential in Late-Stage trial
- 800-Patient study aims to unlock secrets of autoimmune liver disease
- Austrian PBC registry aims to unlock secrets of rare liver disease
- New study tests how liver problems affect PBC drug processing